Clinical Trials Browser

Phase 3 × Active not recruiting × osimertinib × Clear all

Carcinoma, Non-Small-Cell Lung

NCT04765059 2026-04-21

COMPEL

Phase 3 Active not recruiting

98 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05261399 2026-04-06

SAFFRON

Phase 3 Active not recruiting

345 enrolled

Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT05629234 2026-04-06

ROSY-T

Phase 3 Active not recruiting

37 enrolled

Tumor-Agnostic

Neoplasms

NCT02511106 2026-03-30

ADAURA

Phase 3 Active not recruiting

682 enrolled 20 charts 2 FDA

Thoracic

Stage IB-IIIA Non-small Cell Lung Carcinoma

NCT03521154 2026-02-27

LAURA

Phase 3 Active not recruiting

216 enrolled 25 charts 2 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02411448 2026-01-16

RELAY

Phase 3 Active not recruiting

545 enrolled 24 charts 2 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05120349 2026-01-12

ADAURA2

Phase 3 Active not recruiting

390 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04695925 2025-10-15

TOP

Phase 3 Active not recruiting

294 enrolled

Non-small Cell Carcinoma

NCT04035486 2025-10-10

FLAURA2

Phase 3 Active not recruiting

587 enrolled 44 charts 2 FDA

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04351555 2025-05-23

NeoADAURA

Phase 3 Active not recruiting

358 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05015608 2025-05-23

SACHI

Phase 3 Active not recruiting

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

MARIPOSA

COMPEL

SAFFRON

ROSY-T

ADAURA

LAURA

RELAY

ADAURA2

TOP

FLAURA2

NeoADAURA

SACHI